Showing results (1-10 of 3,941) with videos related to

Sort By:
Pageof 395
Current Opinion in Ophthalmology|July 6, 1996
Mechanical methods in refractive corneal surgeryM S Loughnan, D Robinson, L Sullivan
The British Journal of Ophthalmology|July 24, 2001
A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomyR Maini, L Sullivan, G R Snibson, et al.
Australian and New Zealand Journal of Ophthalmology|February 1, 1991
Neovascularisation: has the angiogenic factor already been found?M S Loughnan
The British Journal of Ophthalmology|February 28, 2002
Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndromeR Maini, M S Loughnan
The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1990
A regulatory role for the soluble IL-2 receptor via competition with the p75 cell-surface form of the receptor for IL-2M S Loughnan, G J Nossal
Nature|July 6, 1989
Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chainsM S Loughnan, G J Nossal
Australian and New Zealand Journal of Ophthalmology|August 1, 1992
Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2aM S Loughnan, W J Heriot, J O'Day
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5M S Loughnan, C J Sanderson, G J Nossal
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cellsM S Loughnan, K Takatsu, N Harada, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
Thalidomide is an inhibitor of angiogenesisR J D'Amato, M S Loughnan, E Flynn, et al.
Pageof 395